Search Within

Jose T Baselga

Formats
  1. Meeting Abstract (241)
  2. Journal Article (233)
  3. Conference Paper (4)
  4. Research Letter (3)
  5. Book Section (2)
  6. Review (1)
Groups
  1. Department of Medicine (197)
  2. Solid Tumor Oncology Division (192)
  3. Breast Medicine Service (149)
  4. GSK Faculty (128)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (108)
  6. Human Oncology and Pathogenesis Program (97)

More Groups

People
  1. David Hyman (68)
  2. Maurizio Scaltriti (63)
  3. Clifford Hudis (57)
  4. Michael Berger (56)
  5. Larry Norton (51)
  6. Sarat Chandarlapaty (48)

More People

Years
  1. 2021 (5)
  2. 2020 (11)
  3. 2019 (25)
  4. 2018 (58)
  5. 2017 (68)
  6. 2016 (67)

More Years

Publications
  1. Cancer Research (109)
  2. Journal of Clinical Oncology (92)
  3. Annals of Oncology (29)
  4. Clinical Cancer Research (29)
  5. European Journal of Cancer (25)
  6. Cancer Discovery (13)

More Publications

Publishers
  1. American Association for Cancer Research (163)
  2. American Society of Clinical Oncology (97)
  3. Oxford University Press (41)
  4. Elsevier Inc. (39)
  5. Nature Publishing Group (30)
  6. Springer (16)

More Publishers

Results (484)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BOLERO-2: Efficacy, safety, and quality of life in patients with advanced breast cancer receiving first-line everolimus plus exemestane
    Meeting Abstract

    Campone, M.; Lebrun, F.; Neven, P.; Pistilli, B.; Rugo, H.; Baselga, J.; Brechenmacher, T.; Taran, T.; Sahmoud, T.; Hortobagyi, G.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Minimal molecular alteration in PI3KCA, FGFR1 and CCND1 is associated with increased benefit from everolimus in hormone receptor-positive, HER2-advanced breast cancer: Insights from the BOLERO-2 trial
    Meeting Abstract

    Baselga, J.; Piccart, M.; Gnant, M.; Burris, H.; Chen, D.; Robinson, D.; Huang, A.; McDonald, R.; Taran, T.; Hortobagyi, G.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • PI3KCA mutations and correlation with pCR in the NeoALTTO trial (BIG 01-06)
    Meeting Abstract

    Baselga, J.; Majewski, I.; Nuciforo, P. G.; Eidtmann, H.; Holmes, E.; Sotiriou, C.; Fumagalli, D.; Delgado, M. C. D.; Piccart-Gebhart, M.; Bernards, R.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • The concept of basket trials
    Meeting Abstract

    Baselga, J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Pattern of rash, diarrhea, and hepatic toxicities secondary to neoadjuvant lapatinib and their association with age and pathological complete response (pCR) in breast cancer (BC) patients: Analysis from the NeoALTTO trial
    Meeting Abstract

    Azim, H. A.; Agbor-Tarh, D.; Bradbury, I.; Dinh, P.; Baselga, J.; Di Cosimo, S.; Greger, J. G.; Eidtmann, H.; Piccart, M.; de Azambuja, E.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
    Journal Article

    Azim, H. A. Jr; Agbor-Tarh, D.; Bradbury, I.; Dinh, P.; Baselga, J.; Di Cosimo, S.; Greger, J. G. Jr; Smith, I.; Jackisch, C.; Kim, S. B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Everolimus plus exemestane in postmenopausal patients with HR+ breast cancer: BOLERO-2 final progression-free survival analysis
    Journal Article

    Yardley, D. A.; Noguchi, S.; Pritchard, K. I.; Burris, H. A. 3rd; Baselga, J.; Gnant, M.; Hortobagyi, G. N.; Campone, M.; Pistilli, B.; Piccart, M.; more...
    Advances in Therapy (2013)

    Fulltext@MSK | Save
  • Evaluation and clinical analyses of downstream targets of the akt inhibitor GDC-0068
    Journal Article

    Yan, Y.; Serra, V.; Prudkin, L.; Scaltriti, M.; Murli, S.; Rodríguez, O.; Guzman, M.; Sampath, D.; Nannini, M.; Xiao, Y.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
    Journal Article

    Toy, W.; Shen, Y.; Won, H.; Green, B.; Sakr, R. A.; Will, M.; Li, Z.; Gala, K.; Fanning, S.; King, T. A.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
    Journal Article

    Pritchard, K. I.; Burris, H. A. 3rd; Ito, Y.; Rugo, H. S.; Dakhil, S.; Hortobagyi, G. N.; Campone, M.; Csöszi, T.; Baselga, J.; Puttawibul, P.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save